Therapeutic Effect of Portulaca oleracea‎‎‎ Against Diarrhea ‎Induced by Escherichia coli in Male Rats

Main Article Content

Ahmed M Manthoor
Ali H Saliem



This study aimed to investigate the in vivo antidiarrheal efficacy of methanolic extract ‎of Portulacaoleracea against diarrhea induced by Escherichia coli in male rats. The initial ‎phase involved the ‎extraction of P. oleracea using 99.8% absolute methanol through ‎a Soxhlet extraction apparatus. ‎Phytochemical analyses of the extract unveiled the presence ‎of alkaloids, flavonoids, steroids, ‎carbohydrates, tannins, and proteins. In the experimental ‎phase, 20 Wistar albino male rats (Rattus norvegicus) were divided into four ‎groups: the Negative Control ‎‎(uninfected and untreated); the Positive Control (infected but untreated); ‎POE group consisted of rats infected with E. coli‎‎ (1×109 CFU/mL) and subsequently treated ‎with 200 mg/kg BW of P. oleracea methanolic extract orally ‎twice daily for seven ‎days; and CIP group included rats infected and treated with 7.14 mg/kg BW ‎of ‎ciprofloxacin orally twice daily for seven days. Outcome measures encompassed clinical ‎signs, ‎frequency of watery stools, rectal bacterial count, and changes in BW. ‎Remarkably, both POE and CIP groups demonstrated a statistically significant reduction in the ‎frequency of watery stools ‎‎(P<0.05) and a significant increase in BW (P<0.05) ‎compared to Positive Control group. Notably, there was ‎no significant difference in these parameters ‎between POE and CIP groups, suggesting that P. oleracea ‎methanolic extract performs ‎comparably to ciprofloxacin in treating E. coli‎‎-induced diarrhea. The ‎findings illuminate ‎the potential of herbal medications such as P. oleracea as effective alternatives to ‎antibiotics, ‎thereby mitigating the overuse of antibiotics and the associated risk of bacterial resistance.


Download data is not yet available.

Article Details

How to Cite
Therapeutic Effect of Portulaca oleracea‎‎‎ Against Diarrhea ‎Induced by Escherichia coli in Male Rats. (2023). The Iraqi Journal of Veterinary Medicine, 47(2), 31-36.

How to Cite

Therapeutic Effect of Portulaca oleracea‎‎‎ Against Diarrhea ‎Induced by Escherichia coli in Male Rats. (2023). The Iraqi Journal of Veterinary Medicine, 47(2), 31-36.


Kirk MD, Angulo FJ, Havelaar AH, Black RE. Diarrheal disease in children due to contaminated food. ‎Bull ‎World Health Organ. 2017;95(3):233-234.

‎Suleiman K, Kolo I, Mohammed SS, Magaji YG. Bacterial diarrhea among infants in developing ‎countries: An ‎overview of diarrheagenic Escherichia coli (DEC). Gadau J Pure Alli Sci. 2022;1(1):73-‎‎81.

‎Chae JB, Kim HC, Kang JG, Choi KS, Chae JS, Yu DH, et al. The prevalence of causative agents of calf ‎diarrhea in ‎Korean native calves. J Anim Sci Technol. 2021;63(4):864-872.

Gómez-Simmonds A, Uhlemann AC. Antibiotic Resistance in Escherichia coli. In: Torres C, Johnson JR, ‎editors. ‎Escherichia coli: Pathotypes and Principles of Pathogenesis. 2nd ed. London: Academic Press; ‎‎2018. p. 575-‎‎602.‎

‎Fernandes J, Martínez JL. Antimicrobial Resistance in Escherichia coli. In: Méndez-Vilas A, editor. ‎Microbial ‎pathogens and strategies for combating them: science, technology and education. Badajoz: ‎Formatex Research ‎Center; 2019. p. 103-112.‎

‎Ranasinghe S, Fhogartaigh CN. Bacterial gastroenteritis. Medicine. 2021;49(11):687-693.

‎Ojkic N, Lilja E, Direito S, Dawson A, Allen RJ, Waclaw B. A roadblock-and-kill mechanism of action ‎model for ‎the DNA-targeting antibiotic ciprofloxacin. Antimicrob Agents Chemother. ‎‎2020;64(9):e01012-20.

‎Ennacerie FZ, Filali FR, Najia Moukrad ED. Antibacterial synergistic effect of extracts of the organs of ‎‎Capparis spinosa and in combination with antibiotics. Int J Adv Res. 2017;5(9):1238-1247.‎

‎Nemzer B, Al-Taher F, Abshiru N. Phytochemical composition and nutritional value of different plant ‎parts in ‎two cultivated and wild purslanes (Portulaca oleracea‎‎ L.) genotypes. Food Chem. ‎‎2020;320:126621.

Syed S, Fatima N, Kabeer G. Portulaca oleracea‎‎ L. a mini review on phytochemistry and ‎pharmacology. Int J ‎Biol Sci. 2016;13(4):637-641.‎

‎Du YK, Liu J, Li XM, Pan FF, Wen ZG, Zhang TC, et al. Flavonoids extract from Portulaca oleracea‎‎ L. ‎induce ‎Staphylococcus aureus death by apoptosis-like pathway. Int J Food Prop. 2017;20(sup1):S534-‎S542.

‎Chen D, Yao JN, Liu T, Zhang HY, Li RR, Zhang ZJ, et al. Research and application of Portulaca oleracea‎‎ ‎in ‎pharmaceutical area. Chin Herb Med. 2019;11(2):150-159.

‎Iranshahy M, Javadi B, Iranshahi M, Jahanbakhsh SP, Mahyari S, Hassani FV, et al. A review of ‎traditional uses, ‎phytochemistry and pharmacology of Portulaca oleracea‎‎ L. J Ethnopharmacol. ‎‎2017;205:158-172.‎

‎Jiang Y, Wang X, Xu Z, Wang L, Zhou J, Yu Y, et al. Antibacterial and antidiarrheal activities of ‎Houttuynia ‎cordata Thunb. and Portulaca oleracea‎‎ L. extracts against Enterotoxigenic Escherichia ‎coli‎‎‎. SSRN. 2021;25.

‎Ercisli S, Coruh I, Gormez A, Sengul M. Antioxidant and Antibacterial Activities of Portulaca oleracea‎‎ ‎L. ‎Grown wild in Turkey. Ital J Food Sci. 2008;20(4):479-485.‎

‎Harborne JB. Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis. 4th ed. New ‎Delhi: ‎Springer; 1998. 302 p.‎

‎Ndem JI, Sylvanus PU, Bassey UE, Effiong BO, Ewer EG. Assessing the effect of concomitant ‎administration of ‎artemether-lumefantrine and ciprofloxacin on some cardiac parameters in Wistar ‎rats: "The remedial role of ‎vitamin E". GSC biol pharm sci. 2021;17(1):094-104.‎

‎Eman MA, Hoda MZ. Studies on the effect of garlic preparation on Escherichia coli O157: H7 causing ‎enteritis ‎in lambs. Egyptian J Clin Pathol. 2008;21(4):102-129.‎

‎Oyetayo VO, Adetuyi FC, Akinyosoye FA. Safety and protective effect of Lactobacillus acidophilus and ‎‎Lactobacillus casei used as probiotic agent in vivo. Afr J Biotechnol. 2003;2(11):448-452.

‎Quinn PJ, Carter ME, Markey B, Carter GR. Clinical Veterinary Microbiology. Mosby. Edinburgh, ‎London, New ‎York. 2004. 648 p.‎

‎SAS. Statistical Analysis System, User's Guide. Statistical. Version 9. SAS Inst. Inc. Cary, NC USA; ‎‎2018. 1024 ‎p.‎

Ahmed SA, Shaker SE, Shawky H. Solvent polarity dictates the anti-inflammatory potency and ‎mechanism of ‎two purslanes (Portulaca oleracea‎‎) seed extracts. J Food Biochem. ‎‎2022;46(10):e14281.

Wasnik DD, Tumane PM. Preliminary phytochemical screening and evaluation of antibacterial ‎activity of ‎Portulaca oleracea‎‎ L. against multiple drug resistant (MDR) pathogens isolated from ‎clinical specimen. World ‎J Pharm Res. 2014;3(10):920-931.‎

‎Dhole JA, Dhole NA, Lone KD, Bodke SS. Preliminary phytochemical analysis and antimicrobial ‎activity of ‎some weeds collected from Marathwada region. J Biol Res. 2011;1(1):19-23.‎

‎Ojah EO, Oladele EO, Chukwuemeka P. Phytochemical and antibacterial properties of root extracts ‎from ‎Portulaca oleracea‎‎‎ Linn. (Purslane) utilized in the management of diseases in Nigeria. J Med ‎Plant Econ Dev. ‎‎2021;5(1):103-109.‎

Tarekegn Y, Molla F. The Prevalence of E. coli from diarrheic calves and their antibiotic sensitivity ‎test in ‎selected dairy farms of Debre Zeit, Ethiopia. Adv Biotechnol Microbiol. 2017;6(1):555-559.‎

He Y, Xu G, Jiang P, She D, Huang L, Chen C. Anti-bacterial diarrhea effect and action mechanism of ‎Portulaca ‎oleracea L. water extract based on the regulation of gut microbiota and fecal metabolism. J ‎Sci Food Agric. ‎‎2023;103(1):123-129.‎

Mushtaq N, Redpath MB, Luzio JP, Taylor PW. Treatment of experimental Escherichia coli infection ‎with ‎recombinant bacteriophage-derived capsule depolymerase. J Antimicrob Chemother. ‎‎2005;56(1):160-165.‎

Gunzer F, Hennig-Pauka I, Waldmann KH, Sandhoff R, Gröne HJ, Kreipe HH, et al. Gnotobiotic piglets ‎develop ‎thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli. ‎Am J Clin Pathol. ‎‎2002;118(3):364-375.‎

‎Sultana A, Rahman K. Portulaca oleracea‎‎ Linn. A global Panacea with ethno-medicinal and ‎pharmacological ‎potential. Int J Pharm Pharm Sci. 2013;5(2):33-39.‎

‎Chan K, Islam MW, Kamil MA, Radhakrishnan R, Zakaria MN, ‎Habibullah M, et al. The ‎analgesic and ‎anti-‎‎inflammatory effects of ‎Portulaca oleracea‎‎‎ L. subsp. sativa (Haw.) ‎Celak. J. Ethnopharmacol. ‎‎‎2000;73(3):445-‎‎451‎

‎Manthoor AM, Saliem AH. Evaluation of antibacterial activity of Portulaca oleracea‎‎‎ against Escherichia coli ‎in ‎vitro. Adv Anim Sci. 2023, in press.

Similar Articles

You may also start an advanced similarity search for this article.